{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:04:24Z","timestamp":1771261464744,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,11,1]]},"DOI":"10.1038\/sj.bmt.1702643","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:51:47Z","timestamp":1031154707000},"page":"963-969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)"],"prefix":"10.1038","volume":"26","author":[{"given":"MA","family":"Gertz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MQ","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DA","family":"Gastineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DJ","family":"Inwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MG","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RA","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MR","family":"Litzow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,11,20]]},"reference":[{"key":"BF1702643_CR1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/blood.V75.3.531.531","volume":"75","author":"MJ Stone","year":"1990","unstructured":"Stone MJ . Amyloidosis: a final common pathway for protein deposition in tissues Blood 1990 75: 531\u2013545","journal-title":"Blood"},{"key":"BF1702643_CR2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1742-1241.1978.tb07579.x","volume":"32","author":"AD Mehta","year":"1978","unstructured":"Mehta AD . Regression of amyloidosis in multiple myeloma Br J Clin Pract 1978 32: 358\u2013359, 361","journal-title":"Br J Clin Pract"},{"key":"BF1702643_CR3","first-page":"12 (Abstr.)","volume":"35","author":"MR Persey","year":"1996","unstructured":"Persey MR, Lovat LB, Apperley JF et al. Intensive chemotherapy for AL amyloidosis Br J Rheumatol 1996 35: (Suppl. 1) 12 (Abstr.)","journal-title":"Br J Rheumatol"},{"key":"BF1702643_CR4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V77.2.257.257","volume":"77","author":"MA Gertz","year":"1991","unstructured":"Gertz MA, Kyle RA, Greipp PR . Response rates and survival in primary systemic amyloidosis Blood 1991 77: 257\u2013262","journal-title":"Blood"},{"key":"BF1702643_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","volume":"100","author":"M Skinner","year":"1996","unstructured":"Skinner M, Anderson J, Simms R et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only Am J Med 1996 100: 290\u2013298","journal-title":"Am J Med"},{"key":"BF1702643_CR6","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","volume":"336","author":"RA Kyle","year":"1997","unstructured":"Kyle RA, Gertz MA, Greipp PR et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine New Engl J Med 1997 336: 1202\u20131207","journal-title":"New Engl J Med"},{"key":"BF1702643_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1046\/j.1365-2141.1998.00527.x","volume":"100","author":"JD Gillmore","year":"1998","unstructured":"Gillmore JD, Davies J, Iqbal A et al. Allogeneic bone marrow transplantation for systemic AL amyloidosis Br J Haematol 1998 100: 226\u2013228","journal-title":"Br J Haematol"},{"key":"BF1702643_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/sj.bmt.1700983","volume":"20","author":"B Guillaume","year":"1997","unstructured":"Guillaume B, Straetmans N, Jadoul M et al. Allogeneic bone marrow transplantation for AL amyloidosis Bone Marrow Transplant 1997 20: 907\u2013908","journal-title":"Bone Marrow Transplant"},{"key":"BF1702643_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.7326\/0003-4819-122-7-199504010-00005","volume":"122","author":"M van Buren","year":"1995","unstructured":"van Buren M, Hen\u00e9 RJ, Verdonck LF et al. Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis Ann Intern Med 1995 122: 508\u2013510","journal-title":"Ann Intern Med"},{"key":"BF1702643_CR10","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V91.10.3662","volume":"91","author":"RL Comenzo","year":"1998","unstructured":"Comenzo RL, Vosburgh E, Falk RH et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients Blood 1998 91: 3662\u20133670","journal-title":"Blood"},{"key":"BF1702643_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1046\/j.1365-2141.1998.00772.x","volume":"101","author":"P Moreau","year":"1998","unstructured":"Moreau P, Leblond V, Bourquelot P et al. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients Br J Haematol 1998 101: 766\u2013769","journal-title":"Br J Haematol"},{"key":"BF1702643_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/sj.bmt.1700897","volume":"20","author":"MA Gertz","year":"1997","unstructured":"Gertz MA, Lacy MQ, Inwards DJ et al. Factors influencing platelet recovery after blood cell transplantation in multiple myeloma Bone Marrow Transplant 1997 20: 375\u2013380","journal-title":"Bone Marrow Transplant"},{"key":"BF1702643_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0889-8588(05)70436-6","volume":"11","author":"S Jagannath","year":"1997","unstructured":"Jagannath S, Tricot G, Barlogie B . Autotransplants in multiple myeloma: pushing the envelope Hematol Oncol Clin North Am 1997 11: 363\u2013381","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF1702643_CR14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1182\/blood.V52.4.818.818","volume":"52","author":"RA Kyle","year":"1978","unstructured":"Kyle RA, Greipp PR . Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo Blood 1978 52: 818\u2013827","journal-title":"Blood"},{"key":"BF1702643_CR15","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blad\u00e9","year":"1998","unstructured":"Blad\u00e9 J, Samson D, Reece D et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation Br J Haematol 1998 102: 1115\u20131123","journal-title":"Br J Haematol"},{"key":"BF1702643_CR16","first-page":"45","volume":"32","author":"RA Kyle","year":"1995","unstructured":"Kyle RA, Gertz MA . Primary systemic amyloidosis: clinical and laboratory features in 474 cases Semin Hematol 1995 32: 45\u201359","journal-title":"Semin Hematol"},{"key":"BF1702643_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau J-L, Stoppa A-M et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma New Engl J Med 1996 335: 91\u201397","journal-title":"New Engl J Med"},{"key":"BF1702643_CR18","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1056\/NEJM199706053362307","volume":"336","author":"R Bataille","year":"1997","unstructured":"Bataille R, Harousseau JL . Multiple myeloma New Engl J Med 1997 336: 1657\u20131664","journal-title":"New Engl J Med"},{"key":"BF1702643_CR19","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V87.7.3063.bloodjournal8773063","volume":"87","author":"P Moreau","year":"1996","unstructured":"Moreau P, Milpied N, de Faucal P et al. High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement Blood 1996 87: 3063\u20133064","journal-title":"Blood"},{"key":"BF1702643_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.7326\/0003-4819-123-7-199510010-00017","volume":"123","author":"X Mariette","year":"1995","unstructured":"Mariette X, Clauvel JP, Brouet JC . Intensive therapy in AL amyloidosis and light-chain deposition disease (letter) Ann Intern Med 1995 123: 553","journal-title":"Ann Intern Med"},{"key":"BF1702643_CR21","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1182\/blood.V88.7.2801.bloodjournal8872801","volume":"88","author":"RL Comenzo","year":"1996","unstructured":"Comenzo RL, Vosburgh E, Simms RW et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients Blood 1996 88: 2801\u20132806","journal-title":"Blood"},{"key":"BF1702643_CR22","first-page":"p 60","volume-title":"VIII International Symposium on Amyloidosis","author":"R Comenzo","year":"1998","unstructured":"Comenzo R, Vosburgh E, Falk R et al. High dose melphalan for AL amyloidosis: outcomes in 50 patients VIII International Symposium on Amyloidosis Mayo Clinic: Rochester, MN, August 7\u201311 1998 p 60"},{"key":"BF1702643_CR23","first-page":"p 60","volume-title":"VIII International Symposium on Amyloidosis","author":"JD Gillmore","year":"1998","unstructured":"Gillmore JD, Apperley JF, Craddock C et al. High-dose melphalan and stem cell rescue for AL amyloidosis VIII International Symposium on Amyloidosis Mayo Clinic: Rochester, MN, August 7\u201311 1998 p 60"},{"key":"BF1702643_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.bmt.1701330","volume":"22","author":"A Schulenburg","year":"1998","unstructured":"Schulenburg A, Kalhs P, Oberhuber G et al. Gastrointestinal perforation early after peripheral blood stem cell transplantation for AL amyloidosis Bone Marrow Transplant 1998 22: 293\u2013295","journal-title":"Bone Marrow Transplant"},{"key":"BF1702643_CR25","first-page":"pp 169","volume-title":"Amyloid and Amyloidosis 1998","author":"MA Kazmi","year":"1999","unstructured":"Kazmi MA, Schey SA . Morbidity associated with high dose therapy in primary amyloidosis. In: Kyle RA, Gertz MA (eds) Amyloid and Amyloidosis 1998 Parthenon: London 1999 pp 169\u2013171"},{"key":"BF1702643_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1046\/j.1537-2995.1998.38198141500.x","volume":"38","author":"RL Comenzo","year":"1998","unstructured":"Comenzo RL, Michelle D, LeBlanc M et al. Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and application Transfusion 1998 38: 60\u201369","journal-title":"Transfusion"},{"key":"BF1702643_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/pgmj.68.795.69","volume":"68","author":"MA Devoy","year":"1992","unstructured":"Devoy MA, Tomson CR . Fatal cardiac failure after a single dose of doxorubicin in myeloma-associated cardiac amyloid (letter) Postgrad Med J 1992 68: 69","journal-title":"Postgrad Med J"},{"key":"BF1702643_CR28","first-page":"552","volume":"31","author":"PN Hawkins","year":"1997","unstructured":"Hawkins PN . The diagnosis, natural history and treatment of amyloidosis J R Coll Physicians Lond 1997 31: 552\u2013560","journal-title":"J R Coll Physicians Lond"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702643","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:08:07Z","timestamp":1682035687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,11,1]]}},"alternative-id":["BF1702643"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702643","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11,1]]},"assertion":[{"value":"6 August 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}